Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Topotecan/Cisplatin vs Etoposide/Cisplatin in Extensive Disease SCLC
NCT00043927Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2001
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 34
01
Overview
A Phase 3 trial of topotecan in small cell lung cancer (SCLC), sponsored by GSK. Started Apr 2001; status: completed.
02
Drugs
topotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00043927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043927.